Sunshine Biopharma (SBFM) Competitors

Generation Bio (NASDAQ:GBIO) and Sunshine Biopharma (NASDAQ:SBFM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Do analysts prefer GBIO or SBFM?

Generation Bio currently has a consensus price target of $7.33, suggesting a potential upside of 1,775.53%. Sunshine Biopharma has a consensus price target of $15.00, suggesting a potential upside of 782.35%. Given Generation Bio's higher possible upside, equities research analysts plainly believe Generation Bio is more favorable than Sunshine Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Generation Bio	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sunshine Biopharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders hold more shares of GBIO or SBFM?

95.2% of Generation Bio shares are held by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are held by institutional investors. 21.8% of Generation Bio shares are held by insiders. Comparatively, 0.1% of Sunshine Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is GBIO or SBFM more profitable?

Sunshine Biopharma has a net margin of -12.82% compared to Generation Bio's net margin of -782.86%. Sunshine Biopharma's return on equity of -17.89% beat Generation Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Generation Bio	-782.86%	-104.85%	-49.54%
Sunshine Biopharma	-12.82%	-17.89%	-14.25%

Which has more risk & volatility, GBIO or SBFM?

Generation Bio has a beta of 2.66, indicating that its stock price is 166% more volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Which has higher valuation and earnings, GBIO or SBFM?

Sunshine Biopharma has higher revenue and earnings than Generation Bio. Generation Bio is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Generation Bio	$24.56M	1.07	-$126.61M	-$1.08	-0.36
Sunshine Biopharma	$36.23M	0.21	-$4.51M	-$150.88	-0.01

Does the media refer more to GBIO or SBFM?

In the previous week, Generation Bio and Generation Bio both had 2 articles in the media. Generation Bio's average media sentiment score of 1.43 beat Sunshine Biopharma's score of 0.64 indicating that Generation Bio is being referred to more favorably in the media.

Company	Overall Sentiment
Generation Bio	Positive
Sunshine Biopharma	Positive

Does the MarketBeat Community prefer GBIO or SBFM?

Generation Bio received 46 more outperform votes than Sunshine Biopharma when rated by MarketBeat users. However, 100.00% of users gave Sunshine Biopharma an outperform vote while only 72.73% of users gave Generation Bio an outperform vote.

Company	Underperform	Outperform
Generation Bio	Outperform Votes 48 72.73%	Underperform Votes 18 27.27%
Sunshine Biopharma	Outperform Votes 2 100.00%	Underperform Votes No Votes

Summary

Generation Bio beats Sunshine Biopharma on 9 of the 16 factors compared between the two stocks.